Navigation Links
As Layoffs Increase Nationally, Atlanta's Coverdell Launches Suite of Healthcare Discount Programs; Saving Consumers Up to 60 Percent on Healthcare Spending
Date:3/10/2009

Atlanta-based Coverdell this week launched Reassurance Health -- a new suite of affordable healthcare discounts programs that will allow consumers nationwide to save up to 60 percent on out-of-pocket healthcare costs. Reassurance Health offers seven individual and family programs -- with discounts on services such as over-the-counter medicines, hospital care, and flat-rate reimbursement for doctor visits.

Atlanta, GA (PRWEB) March 10, 2009 -- With the massive layoffs of the past week, unemployment has risen to levels not seen for decades, making quality healthcare either too expensive or simply unavailable for millions. Atlanta-based Coverdell this week launched Reassurance Health (http://www.reassurancehealth.com/) -- a new suite of affordable healthcare discounts programs that will allow consumers nationwide to save up to 60 percent on out-of-pocket healthcare costs. Reassurance Health offers seven individual and family programs -- with discounts on services such as over-the-counter medicines, hospital care, and flat-rate reimbursement for doctor visits.

Coverdell is a leading provider and innovator in non-insurance health benefit programs, with programs currently serving more than six million members nationwide.

"Reassurance Health is a low-cost alternative that offers partial reimbursement for doctor visits, hospital visits, and accident and emergency medical care," said Vincent DiBenedetto, CEO, Coverdell. "The Reassurance Health programs are not health insurance, but are a great way for anyone to save money on every aspect of their healthcare. The Reassurance Health healthcare discount programs are easy to use, cover a mul
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. South Florida Dermatologists Win Over Golf Fans With Sun Safety Outreach at LPGA Playoffs
2. Healthcare Workers Rally to Address Concerns About Layoffs and Quality Patient Care
3. Brits Love Affair with Holiday Cosmetic Surgery Creates Increase in UK Corrective Surgery
4. ASPS Applauds Introduction of Legislation to Increase Access to Reconstructive Surgery for Children
5. Cantel Medical Reports 75% Increase in Net Income - EPS of $0.23 vs. $0.13 for Quarter Ended January 31, 2009
6. Florida Emergency Room Costs Increased 25 Percent in the Last Year and May Lead to More Opportunity for Pharma Industry
7. Donate Life Day at the Capitol to Increase Awareness for Organ Donation and Registration
8. Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer
9. Brain tumor treatment may increase number of cancer stem-like cells
10. Consumers Beware: Unlicensed Care of Animals May Cause Health Problems and Increased Costs
11. Penile extender increased flaccid length by almost a third says independent clinical study

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
As Layoffs Increase Nationally, Atlanta's Coverdell Launches Suite of Healthcare Discount Programs; Saving Consumers Up to 60 Percent on Healthcare Spending
As Layoffs Increase Nationally, Atlanta's Coverdell Launches Suite of Healthcare Discount Programs; Saving Consumers Up to 60 Percent on Healthcare Spending
(Date:11/23/2009)...ctoryPharma,Inc.("Victory")announcedtodaythelaunch...y,sNAPRELANfranchise. ,, NAPRELANDoseCardisdesi...ainandinflammationassociatedwithprimarydysmenorrhe...patientssufferingfromrheumatoidarthritisorosteoart...onalanti-inflammatory/analgesicactivityforalimited...
(Date:11/23/2009)...n the November issue of GIE: Gastrointestinal End...nal of the American Society for Gastrointestinal E...y found that Barrett,s esophagus was detected in s...opic screening. Also in this issue, two studies ex...om France, in the largest single-center experience...
(Date:11/23/2009)...build-up of a brain peptide called amyloid-beta. T...us of almost all drug research pursuing a cure for...But that may be counterproductive, says Dr. Inna S...iology and Pharmacology, Sackler Faculty of Medici...beta is also necessary to maintain proper brain fu...
(Date:11/23/2009)...Call/--AnnTaylorStoresCorp.announcedtodaythatitwil...sandGivingcampaign,aholidayfundraisingandawareness...armarksthethirdyearthatAnnTaylor,throughitsANNCARE...mpaignwhereweofferourshoppersanopportunitytohelpsa...hisholidayseason.ClientswhoshopatAnnTaylor,Loft,An...
(Date:11/23/2009)...ed longer-term support than most friends, relative...ing to a study of 160 patients published in the De...Nursing . , Researchers surveyed 55 patients...her with 105 who had had surgery in the last one t...in Tennessee, USA. They wanted to see if there was...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Upending textbook science on Alzheimer's disease 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3
...ntists from University of California have develope...cells which could help in the treatment of spinal ...ing results in the stimulation of nerve cells in l...oung and doesnot grow when it has become old, the ...
...essor Karen Gripp and his team from DuPont Hospita...ad to Costello Syndrome, scientists found that the...it was not observed in the genotype of the parents...don 12 or 13 in the H-ras gene in 85% patients. Th...
...Lancet has published a new study which challenges ...od to the heart. The study asserts that the harm i...benefits. Conventional medical wisdom states that ...ealand cite a large US study published earlier thi...
...search team of scientists at the Columbia Universi...eight when compared to keeping it off. // The key ...ppetite. The hormone helped people to avoid puttin...he metabolic thermostat of the body is reset upwar...
...galese schoolchildren took a pledge to abstain fro...DS Day. The prevailing taboos in the developing na...ntributing towards the disease spreading rapidly. ...courge is continuing to take a heavy toll in the A...
...ish researchers have expressed hope regarding the ...virus. The first phase of the clinical trials have...volunteers. DNA vaccines represent the lates... vaccines precipitate an immune response so that t...
Other Medicine News:Health News:DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope 2
(Date:11/23/2009)...ire-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"...sentationofclinicaltrialdataonNGX426,theCompany,so...ntagonist,atthe12thInternationalConferenceontheMec...r20-21inSanFrancisco.TheresultsofthestudyledbyMark...eCenterforPainMedicineoftheUniversityofCaliforniaa...
(Date:11/23/2009)...ewswire-FirstCall/--NeurobiologicalTechnologies,In...ofdirectorshasdeclaredanextraordinarydividendof$0....,2009tostockholdersofrecordasofNovember30,2009.The...derapprovalofthedissolutionofNTIpursuanttoaplanofc...rdinarydividendof$0.75persharethatwaspaidtoshareho...
(Date:11/20/2009)...swire/ -- The United States Court of Appeals for ... ruling yesterday, approving a settlement in the l...utical litigation against AstraZeneca Pharmaceutic...gi-bin/prnh/20080317/AQM144LOGO ) ,, The ruling...urchased the pharmaceutical giant,s prostate cance...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 1HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 2HEALTHeCAREERS Network Renews 2415 000 Scholarship Pledge 59787 3Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2
...Mo.--(BUSINESS WIRE)--May 4, 2007 - New data have,...erosis (RRMS),patients treated with COPAXONE(R) (g...osuppression with mitoxantrone experienced a,90 pe...)-monitored,disease activity compared to their bas...ere sustained throughout the 24-month study,period...
...ngland, 4th May 2007 - CeNeS Pharmaceuticals plc,(...ompany, notes,the publication of an independent st... on its Phase II NMDA antagonist, CNS 5161. CeNeS,...r neuropathic,pain. The independent study builds o...CNS 5161. , In the study reported in ,Synapse, Dr...
Other Medicine Technology:Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
Vitreoretinal Viscodissector 90 degrees
Infusion Cannula 6mm
DCR Set
IOL Manipulator - Sinskey
Medicine Products: